Skip to main content
. 2017 Jul 5;8(34):57278–57301. doi: 10.18632/oncotarget.18985

Table 9. KNN classification-based predictions of GS with subsets of 30,000 cells and Biomarkers I.

A Classification
ID B 3+3 3+4 4+3 Total
HPrEpiC 1,672 166 33 195 2,066
% 80.93 8.03 1.6 9.44 100
LNCaP 85 507 13,482 3,363 17,437
% 0.49 2.91 77.32 19.29 100
B Classification
ID B 3+3 3+4 4+3 Total
Patient 5 0 67 6,323 5,195 11,585
% 0 0.58 54.58 44.84 100
Patient Z 222 792 3,500 4,860 9,374
% 2.37 8.45 37.34 51.85 100
C Classification
Phase B 3+3 3+4 4+3 Total
B1 254 329 539 1,597 2,719
% 9.34 12.1 19.82 58.73 100
% 1.71 2.67 26.58 69.04 100
D Classification
ID B 3+3 3+4 4+3 Total
Patient 7 13 117 1,705 3,794 5,629
% 0.23 2.08 30.29 67.4 100
Patient 8 183 1,176 3,086 4,070 8,515
% 2.15 13.81 36.24 47.8 100